FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eduardo Charreau

Research Profile

Disorders

Living Beings

Chemicals & Drugs

Physiology

Cell Divisions

Anatomy

Tumor Cells, Cultured

Co-author Network

Publications

TOP 3
Ianina Ferder; Karina Gómez; Fernanda Parborell; Victoria Sundblad; Marta Tesone; Eduardo H Charreau; Violeta A Chiauzzi; Liliana Dain
Expression of fragile X mental retardation protein and Fmr1 mRNA during folliculogenesis in the rat.
Mercedes Tkach; Wendy Beguelin; Juliana Cassataro; Eduardo H Charreau; Lorena Coria; María Celeste Díaz Flaqué; Patricia V Elizalde; Isabel Frahm; Cecilia J Proietti; Martin Alfredo Rivas; Cinthia Rosemblit; Roxana Schillaci
Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cells.
Roxana Schillaci; Wendy Beguelin; Florencia Cayrol; Eduardo H Charreau; María C Díaz Flaqué; Isabel Frahm; Pablo Guzmán; Esteban Maronna; Jorge Palazzi; Viviana Pineda; Cecilia J Proietti; Juan C Roa; Patricia V Elizalde
Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eduardo Charreau (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ianina Ferder; Karina Gómez; Fernanda Parborell; Victoria Sundblad; Marta Tesone; Eduardo H Charreau; Violeta A Chiauzzi; Liliana Dain
Expression of fragile X mental retardation protein and Fmr1 mRNA during folliculogenesis in the rat.
Reproduction (Cambridge, England) 2013;145(4):335-43.
2012: Mercedes Tkach; Wendy Beguelin; Juliana Cassataro; Eduardo H Charreau; Lorena Coria; María Celeste Díaz Flaqué; Patricia V Elizalde; Isabel Frahm; Cecilia J Proietti; Martin Alfredo Rivas; Cinthia Rosemblit; Roxana Schillaci
Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2012;189(3):1162-72.
2012: Roxana Schillaci; Wendy Beguelin; Florencia Cayrol; Eduardo H Charreau; María C Díaz Flaqué; Isabel Frahm; Pablo Guzmán; Esteban Maronna; Jorge Palazzi; Viviana Pineda; Cecilia J Proietti; Juan C Roa; Patricia V Elizalde
Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer.
BMC cancer 2012;12():74.
2011: Cecilia J Proietti; Wendy Béguelin; María Celeste Díaz Flaqué; Florencia Cayrol; Martin Alfredo Rivas; Mercedes Tkach; Eduardo H Charreau; Roxana Schillaci; Patricia V Elizalde
Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer.
Steroids 2011;76(4):381-92.
2011: Eduardo H Charreau
[Argentine science and its diaspora].
Medicina 2011;71(2):194-5.
2011: Carolina Minutolo; Alejandro D Nadra; Cecilia Fernández; Melisa Taboas; Noemí Buzzalino; Bárbara Casali; Susana Belli; Eduardo H Charreau; Liliana Alba; Liliana Dain
Structure-based analysis of five novel disease-causing mutations in 21-hydroxylase-deficient patients.
PloS one 2011;6(1):e15899.
2010: Wendy Béguelin; María Celeste Díaz Flaqué; Cecilia J Proietti; Florencia Cayrol; Martin Alfredo Rivas; Mercedes Tkach; Cinthia Rosemblit; Johanna M Tocci; Eduardo H Charreau; Roxana Schillaci; Patricia V Elizalde
Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3.
Molecular and cellular biology 2010;30(23):5456-72.
2010: Martin Alfredo Rivas; Mercedes Tkach; Wendy Beguelin; Cecilia J Proietti; Cinthia Rosemblit; Eduardo H Charreau; Patricia V Elizalde; Roxana Schillaci
Transactivation of ErbB-2 induced by tumor necrosis factor alpha promotes NF-kappaB activation and breast cancer cell proliferation.
Breast cancer research and treatment 2010;122(1):111-24.
2009: Cecilia J Proietti; Cinthia Rosemblit; Wendy Beguelin; Martin Alfredo Rivas; María Celeste Díaz Flaqué; Eduardo H Charreau; Roxana Schillaci; Patricia V Elizalde
Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth.
Molecular and cellular biology 2009;29(5):1249-65.
2008: Martin Alfredo Rivas; Romina Carnevale; Cecilia J Proietti; Cinthia Rosemblit; Wendy Beguelin; Mariana Salatino; Eduardo H Charreau; Isabel Frahm; Sandra Sapia; Peter Brouckaert; Patricia V Elizalde; Roxana Schillaci
TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.
Experimental cell research 2008;314(3):509-29.
2008: Eduardo H Charreau
[Celebration of the fiftieth anniversary of CONICET].
Medicina 2008;68(3):261-2.
2007: Romina Carnevale; Cecilia J Proietti; Mariana Salatino; Alejandro J Urtreger; Guillermo Peluffo; Dean P Edwards; Viroj Boonyaratanakornkit; Eduardo H Charreau; Elisa Bal de Kier Joffé; Roxana Schillaci; Patricia V Elizalde
Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.
Molecular endocrinology (Baltimore, Md.) 2007;21(6):1335-58.
2006: Mariana Salatino; W Beguelin; M G Peters; Romina Carnevale; Cecilia J Proietti; M D Galigniana; Cleber Giovane Vedoy; Roxana Schillaci; Eduardo H Charreau; Mari C Sogayar; Patricia V Elizalde
Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation.
Oncogene 2006;25(59):7723-39.
2006: Victoria Sundblad; Leonardo Bussmann; Violeta A Chiauzzi; utkarsh pancholi; Eduardo H Charreau
Alpha-enolase: a novel autoantigen in patients with premature ovarian failure.
Clinical endocrinology 2006;65(6):745-51.
2006: Victoria Sundblad; Violeta A Chiauzzi; Luz Andreone; Stella Campo; Eduardo H Charreau; Liliana Dain
Controversial role of inhibin alpha-subunit gene in the aetiology of premature ovarian failure.
Human reproduction (Oxford, England) 2006;21(5):1154-60.
2006: Liliana Dain; Carolina Minutolo; N Buzzalino; Susana Belli; Adriana Oneto; Eduardo H Charreau; Liliana G Alba
Gene symbol: CYP21A2. Disease: adrenal hyperplasia, CYP21.
Human genetics 2006;119(3):363.
2006: Roxana Schillaci; Mariana Salatino; Juliana Cassataro; Cecilia J Proietti; Guillermo H Giambartolomei; Martin Alfredo Rivas; Romina Carnevale; Eduardo H Charreau; Patricia V Elizalde
Immunization with murine breast cancer cells treated with antisense oligodeoxynucleotides to type I insulin-like growth factor receptor induced an antitumoral effect mediated by a CD8+ response involving Fas/Fas ligand cytotoxic pathway.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(6):3426-37.
2006: Pablo J Enriori; Stella Maris Vázquez; Violeta A Chiauzzi; Cecilia Pérez; Carlos R Fischer; Jorge R Gori; Alberto E Etkin; Eduardo H Charreau; Ricardo S Calandra; Isabel Alicia Lüthy
Breast cyst fluids increase the proliferation of breast cell lines in correlation with their hormone and growth factor concentration.
Clinical endocrinology 2006;64(1):20-8.
2005: Cecilia J Proietti; Mariana Salatino; Cinthia Rosemblit; Romina Carnevale; Adali Pecci; Alberto R Kornblihtt; Alfredo A Molinolo; Isabel Frahm; Eduardo H Charreau; Roxana Schillaci; Patricia V Elizalde
Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.
Molecular and cellular biology 2005;25(12):4826-40.
2004: Victoria Sundblad; Violeta A Chiauzzi; Maria Eugenia Escobar; Liliana Dain; Eduardo H Charreau
Screening of FSH receptor gene in Argentine women with premature ovarian failure (POF).
Molecular and cellular endocrinology 2004;222(1-2):53-9.
2004: Violeta A Chiauzzi; Leonardo Bussmann; Juan Carlos Calvo; Victoria Sundblad; Eduardo H Charreau
Circulating immunoglobulins that inhibit the binding of follicle-stimulating hormone to its receptor: a putative diagnostic role in resistant ovary syndrome?
Clinical endocrinology 2004;61(1):46-54.
2004: Mariana Salatino; Roxana Schillaci; Cecilia J Proietti; Romina Carnevale; Isabel Frahm; Alfredo A Molinolo; Adolfo Iribarren; Eduardo H Charreau; Patricia V Elizalde
Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
Oncogene 2004;23(30):5161-74.
2004: Mariana Salatino; Roxana Schillaci; Cecilia J Proietti; Romina Carnevale; Eduardo H Charreau; Patricia V Elizalde
[Type I insulin-like growth factor receptor antisense strategies in experimental breast cancer].
Medicina 2004;64(2):129-34.
2003: Sara I Marí; Vanesa Y Rawe; Juan Carlos Biancotti; Eduardo H Charreau; Liliana Dain; Mónica H Vazquez-Levin
Biochemical and molecular studies of the proacrosin/acrosin system in patients with unexplained infertility.
Fertility and sterility 2003;79 Suppl 3():1676-9.
2003: Leticia Labriola; Mariana Salatino; Cecilia J Proietti; Adali Pecci; Omar A Coso; Alberto R Kornblihtt; Eduardo H Charreau; Patricia V Elizalde
Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells.
Molecular and cellular biology 2003;23(3):1095-111.
2002: Lydia Puricelli; Cecilia J Proietti; Cecilia J Proiettii; Leticia Labriola; Mariana Salatino; Maria Balañá; Julio A Aguirre Ghiso; Ruth Lupu; Omar P Pignataro; Eduardo H Charreau; Elisa Bal de Kier Joffé; Patricia V Elizalde
Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells.
International journal of cancer. Journal international du cancer 2002;100(6):642-53.
2002: Liliana Dain; Noemí D Buzzalino; Adriana Oneto; Susana Belli; Mirta Stivel; Titania Pasqualini; Carolina Minutolo; Eduardo H Charreau; Liliana G Alba
Classical and nonclassical 21-hydroxylase deficiency: a molecular study of Argentine patients.
Clinical endocrinology 2002;56(2):239-45.
2001: Mariana Salatino; Leticia Labriola; Roxana Schillaci; Eduardo H Charreau; Patricia V Elizalde
Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
Experimental cell research 2001;265(1):152-66.
2001: M G Peters; Silvia I Vanzulli; Patricia V Elizalde; Eduardo H Charreau; M M Goin
Effects of antiprogestins RU486 and ZK98299 on the expression of cell cycle proteins of a medroxyprogesterone acetate (MPA)-induced murine mammary tumor.
Oncology reports 2001;8(2):445-9.
2001: Maria Balañá; Leticia Labriola; Mariana Salatino; F Movsichoff; G Peters; Eduardo H Charreau; Patricia V Elizalde
Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells.
Oncogene 2001;20(1):34-47.
2000: Laura I Furlong; U Hellman; A Krimer; Jorge G Tezón; Eduardo H Charreau; Mónica H Vazquez-Levin
Expression of human proacrosin in Escherichia coli and binding to zona pellucida.
Biology of reproduction 2000;62(3):606-15.
1999: Maria Balañá; R Lupu; Leticia Labriola; Eduardo H Charreau; Patricia V Elizalde
Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas.
Oncogene 1999;18(46):6370-9.
1999: M H Viegas; Mariana Salatino; M Goin; G Peters; Leticia Labriola; J Costa da cunha; Claudia Lanari; Eduardo H Charreau; Patricia V Elizalde
Differential expression of and responsiveness to transforming growth factor-beta (TGF-beta) isoforms in hormone-dependent and independent lines of mouse mammary tumors.
Cancer detection and prevention 1999;23(5):375-86.
1999: MF Montecchia; Caroline Lamb; Alfredo A Molinolo; IA Luthy; Patricia Pazos; Eduardo H Charreau; Silvia I Vanzulli; Claudia Lanari
Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas.
The Journal of steroid biochemistry and molecular biology 1999;68(1-2):11-21.
1998: Patricia V Elizalde; Claudia Lanari; Alfredo A Molinolo; F K Guerra; Maria Balañá; Marina Simian; A M Iribarren; Eduardo H Charreau
Involvement of insulin-like growth factors-I and -II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas.
The Journal of steroid biochemistry and molecular biology 1998;67(4):305-17.
1998: Patricia Pazos; Claudia Lanari; Patricia V Elizalde; F Montecchia; Eduardo H Charreau; Alfredo A Molinolo
Promoter effect of medroxyprogesterone acetate (MPA) in N-methyl-N-nitrosourea (MNU) induced mammary tumors in BALB/c mice.
Carcinogenesis 1998;19(3):529-31.
1997: Patricia V Elizalde; M E Balaña; Eduardo H Charreau
[Growth hormones and oncogenes in mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice].
Medicina 1997;57 Suppl 2():70-4.
1996: K Del Punta; Eduardo H Charreau; Omar P Pignataro
Nitric oxide inhibits Leydig cell steroidogenesis.
Endocrinology 1996;137(12):5337-43.
1996: L E Bussmann; I M Bussmann; Eduardo H Charreau
Role of receptors for epidermal growth factor and insulin-like growth factors I and II in the differentiation of rat mammary glands from lactogenesis I to lactogenesis II.
Journal of reproduction and fertility 1996;107(2):307-14.
1996: F K Guerra; A M Eijan; Lydia Puricelli; DANIEL ALONSO; Elisa Bal de Kier Joffé; A R Kornblihgtt; Eduardo H Charreau; Patricia V Elizalde
Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability.
International journal of cancer. Journal international du cancer 1996;65(6):812-20.
1995: G Dran; I A Luthy; Alfredo A Molinolo; F Montecchia; Eduardo H Charreau; C D Pasqualini; Claudia Lanari
Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma.
Breast cancer research and treatment 1995;35(2):173-86.
1995: Patricia V Elizalde; F K Guerra; M Gravano; Claudia Lanari; Marc Lippman; Eduardo H Charreau; R Lupu
Correlation of TGF-beta 1 expression with medroxyprogesterone acetate responsiveness in mouse mammary adenocarcinomas.
Cancer investigation 1995;13(2):173-80.
1995: E A Vladusic; Omar P Pignataro; L E Bussmann; Eduardo H Charreau
Regulation of the cholesterol ester cycle and progesterone synthesis by juvenile hormone in MA-10 Leydig tumor cells.
The Journal of steroid biochemistry and molecular biology 1995;52(1):83-90.
1994: E C Kordon; F Guerra; Alfredo A Molinolo; Patricia V Elizalde; Eduardo H Charreau; C D Pasqualini; F Montecchia; Patricia Pazos; G Dran; Claudia Lanari
Effect of sialoadenectomy on medroxyprogesterone-acetate-induced mammary carcinogenesis in BALB/c mice. Correlation between histology and epidermal-growth-factor receptor content.
International journal of cancer. Journal international du cancer 1994;59(2):196-203.
1994: E A Vladusic; L E Bussmann; P E Visconti; A M Stoka; Juan B Rodriguez; Eduardo G Gros; Eduardo H Charreau
Effects of juvenile hormone on mammalian steroidogenesis.
The Journal of steroid biochemistry and molecular biology 1994;50(3-4):181-7.
1993: E C Kordon; Alfredo A Molinolo; C D Pasqualini; Eduardo H Charreau; Patricia Pazos; G Dran; Claudia Lanari
Progesterone induction of mammary carcinomas in BALB/c female mice. Correlation between progestin dependence and morphology.
Breast cancer research and treatment 1993;28(1):29-39.
1993: F K Guerra; G M Ciuffo; Patricia V Elizalde; Eduardo H Charreau; J M Saavedra
Enhanced expression of angiotensin II receptor subtypes and angiotensin converting enzyme in medroxyprogesterone-induced mouse mammary adenocarcinomas.
Biochemical and biophysical research communications 1993;193(1):93-9.
1993: L B Fuentes; J C Calvo; Eduardo H Charreau; JA Guzmán
Seasonal variations in testicular LH, FSH, and PRL receptors; in vitro testosterone production; and serum testosterone concentration in adult male vizcacha (Lagostomus maximus maximus).
General and comparative endocrinology 1993;90(2):133-41.
1992: Patricia Pazos; Claudia Lanari; R Meiss; Eduardo H Charreau; C D Pasqualini
Mammary carcinogenesis induced by N-methyl-N-nitrosourea (MNU) and medroxyprogesterone acetate (MPA) in BALB/c mice.
Breast cancer research and treatment 1992;20(2):133-8.
1991: E Kordon; Claudia Lanari; Alfredo A Molinolo; Patricia V Elizalde; Eduardo H Charreau; C Dosne Pasqualini
Estrogen inhibition of MPA-induced mouse mammary tumor transplants.
International journal of cancer. Journal international du cancer 1991;49(6):900-5.
1991: L B Dain; P Stein; A R Krimer; R H Asch; E P de Fried; Eduardo H Charreau; Marta Tesone
Progesterone production in cultured human granulosa cells: correlation with follicular fluid hormone levels.
Fertility and sterility 1991;55(6):1093-8.
1991: Levalle Oscar; M O Suescun; L Fiszlejder; S Aszpis; Eduardo H Charreau; A Guitelman; Ricardo S Calandra
Effect of an antiestrogen on the testicular response to acute and chronic administration of hCG in normal and hypogonadotropic hypogonadic men: tamoxifen and testicular response to hCG.
Andrologia 1991;23(2):109-14.
1991: Tomás Santa Coloma; R J Rossi; Eduardo H Charreau
Solid-phase assay for determination of binding parameters of ligand-protein complexes with high dissociation rates.
Analytical biochemistry 1991;192(2):367-71.
1990: E Kordon; Claudia Lanari; R Meiss; Patricia V Elizalde; Eduardo H Charreau; C Dosne Pasqualini
Hormone dependence of a mouse mammary tumor line induced in vivo by medroxyprogesterone acetate.
Breast cancer research and treatment 1990;17(1):33-43.
1990: Patricia V Elizalde; Claudia Lanari; E Kordon; Jorge G Tezón; Eduardo H Charreau
Transforming growth factor-beta activities in 'in vivo' lines of hormone-dependent and independent mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice.
Breast cancer research and treatment 1990;16(1):29-39.
1990: Claudia Lanari; Alfredo A Molinolo; E Kordon; C D Pasualini; Eduardo H Charreau
Progesterone receptors in estrogen-induced fibromatosis of guinea pigs.
Cancer letters 1990;51(3):235-45.
1990: M D Leon; J C Calvo; Eduardo H Charreau; Hector E Chemes
Developmental changes in testicular interstitial cell populations, LH receptors and in the response to hCG in the rat.
International journal of andrology 1990;13(2):110-22.
1990: Patricia V Elizalde; Eduardo H Charreau
Alpha-transforming growth factorlike activities and bifunctional regulators of cell growth in human malignant neoplasms.
Cancer investigation 1990;8(3-4):365-74.
1989: Claudia Lanari; E Kordon; Alfredo A Molinolo; C D Pasqualini; Eduardo H Charreau
Mammary adenocarcinomas induced by medroxyprogesterone acetate: hormone dependence and EGF receptors of BALB/c in vivo sublines.
International journal of cancer. Journal international du cancer 1989;43(5):845-50.
1989: Patricia E Saragüeta; A R Krimer; Eduardo H Charreau; Marta Tesone
Insulin regulation of steroidogenic activity in rat culture luteal cells.
Journal of steroid biochemistry 1989;32(3):393-7.
1987: C B Gonzalez; Eduardo H Charreau; A Aragonés; Carlos P Lantos; B K Follett
The ontogenesis of reproductive hormones in the female embryo of the domestic fowl.
General and comparative endocrinology 1987;68(3):369-74.
1987: Alfredo A Molinolo; Claudia Lanari; Eduardo H Charreau; N Sanjuan; C D Pasqualini
Mouse mammary tumors induced by medroxyprogesterone acetate: immunohistochemistry and hormonal receptors.
Journal of the National Cancer Institute 1987;79(6):1341-50.
1987: M D Crespi; J P Radicella; Alberto Baldi; Eduardo H Charreau; J C Calvo
DNA topoisomerase I from Leydig cells is modulated by luteinizing hormone and cyclic adenosine monophosphate.
Molecular and cellular endocrinology 1987;53(3):221-6.
1987: Tomás Santa Coloma; M A Bley; Eduardo H Charreau
Improvement on the competitive binding assay for the measurement of cyclic AMP by using ammonium sulphate precipitation.
The Biochemical journal 1987;245(3):923-4.
1987: M T Téllez-Iñón; R G Ladenheim; R Ulloa; Eduardo H Charreau; Marta Tesone
Regulation by insulin of cyclic nucleotide phosphodiesterase (PDE) from rat luteal cells.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1987;19(6):249-52.
1987: Tomás Santa Coloma; H Martin Garraffo; Eduardo G Gros; Eduardo H Charreau
Cyclic biospecific affinity chromatographic method for the purification of the sex steroid binding protein (SBP): application to the purification of SBP from toad.
Journal of chromatography 1987;415(2):297-304.
1987: M D León; V A Chiauzzi; J C Calvo; Eduardo H Charreau; Hector E Chemes
Acute hCG administration induces seminiferous tubule damage in the adult rat.
Acta physiologica et pharmacologica latinoamericana : organo de la Asociación Latinoamericana de Ciencias Fisiológicas y de la Asociación Latinoamericana de Farmacología 1987;37(2):277-88.
1986: Marta Tesone; R G Ladenheim; R Cheb-Terrab; V Chiauzzi; A Solano; E Podesta; Eduardo H Charreau
Comparison between bioactive and immunoactive luteinizing hormone (LH) in ovariectomized streptozotocin-induced diabetic rats: response to LH-releasing hormone.
Endocrinology 1986;119(6):2412-6.
1986: J C Calvo; J L Sagripanti; L E Peltzer; J A Guzman; Eduardo H Charreau
Photoperiod, follicle-stimulating hormone receptors, and testicular function in vizcacha (Lagostomus maximus maximus).
Biology of reproduction 1986;35(4):822-7.
1986: Tomás Santa Coloma; J P Muschietti; Eduardo H Charreau
Sex steroid binding protein from Bufo arenarum: further characterization.
Comparative biochemistry and physiology. A, Comparative physiology 1986;85(3):401-5.
1985: Marta Tesone; R G Ladenheim; Eduardo H Charreau
Alterations in the prolactin secretion in streptozotocin-induced diabetic rats. Correlation with pituitary and hypothalamus estradiol receptors.
Molecular and cellular endocrinology 1985;43(2-3):135-40.
1985: Tomás Santa Coloma; S Fernandez; Eduardo H Charreau
Characterization of a sexual steroid binding protein in Bufo arenarum.
General and comparative endocrinology 1985;60(2):273-9.
1985: J P Radicella; J C Calvo; Eduardo H Charreau
Effects of radioiodination on hormone binding ability.
Journal of receptor research 1985;5(5-6):349-65.
1985: I A Lüthy; E T Segura; V I Lüthy; Eduardo H Charreau; Ricardo S Calandra
Prolactin binding sites in the brain and kidneys of the toad, Bufo arenarum Hensel.
Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology 1985;155(5):611-4.
1985: I A Lüthy; Marta Tesone; R M Oliveira-Filho; Gustavo Somoza; Eduardo H Charreau; Carlos Libertun; Ricardo S Calandra
Effect of median eminence lesions and hormonal replacement on the prolactin receptors in the adrenal gland and Langerhans islets from ovariectomized adult rats.
Journal of receptor research 1985;5(1):105-19.
1984: R G Ladenheim; Marta Tesone; Eduardo H Charreau
Insulin action and characterization of insulin receptors in rat luteal cells.
Endocrinology 1984;115(2):752-6.
1984: Tomás Santa Coloma; H Martin Garraffo; Omar P Pignataro; Eduardo H Charreau; Eduardo G Gros
Biosynthesis of bufadienolides in toads. V. The origin of the cholesterol used by toad parotid glands for biosynthesis of bufadienolides.
Steroids 1984;44(1):11-22.
1984: Marta Tesone; R G Ladenheim; V A Chiauzzi; Eduardo H Charreau
Effect of prolactin on the steroidogenic response of rat luteal cells.
Molecular and cellular endocrinology 1984;36(3):187-94.
1984: J C Calvo; J L Barañao; Marta Tesone; Eduardo H Charreau
Hypothalamic-hypophyseal-gonadal axis in the streptozotocin-induced diabetic male rat.
Journal of steroid biochemistry 1984;20(3):769-72.
1984: J C Calvo; J P Radicella; Omar P Pignataro; Eduardo H Charreau
Effect of a second injection of human chorionic gonadotropin on the desensitized Leydig cells.
Molecular and cellular endocrinology 1984;34(1):31-8.
1984: I A Lüthy; V A Chiauzzi; Eduardo H Charreau; Ricardo S Calandra
Effects of prolactin, bromocriptine and sulpiride on estrogen and lactogenic receptors in the rat adrenal gland.
Acta physiologica et pharmacologica latinoamericana : organo de la Asociación Latinoamericana de Ciencias Fisiológicas y de la Asociación Latinoamericana de Farmacología 1984;34(1):15-23.
1983: Omar P Pignataro; J P Radicella; J C Calvo; Eduardo H Charreau
Mitochondrial biosynthesis of cholesterol in Leydig cells from rat testis.
Molecular and cellular endocrinology 1983;33(1):53-67.
1983: Marta Tesone; R G Ladenheim; R M Oliveira-Filho; V A Chiauzzi; V G Foglia; Eduardo H Charreau
Ovarian dysfunction in streptozotocin-induced diabetic rats.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1983;174(1):123-30.
1983: J C Calvo; J P Radicella; Eduardo H Charreau
Measurement of specific radioactivities in labelled hormones by self-displacement analysis.
The Biochemical journal 1983;212(2):259-64.
1983: Marta Tesone; I A Lüthy; R G Ladenheim; Ricardo S Calandra; Eduardo H Charreau
Prolactin regulation of prolactin binding sites in pancreatic islets and adrenal glands of ovariectomized rats.
Journal of receptor research 1983;3(6):711-26.
1982: V Chiauzzi; Selva B Cigorraga; María Eugenia Escobar; Marco A Rivarola; Eduardo H Charreau
Inhibition of follicle-stimulating hormone receptor binding by circulating immunoglobulins.
The Journal of clinical endocrinology and metabolism 1982;54(6):1221-8.
1982: Marta Tesone; R M Oliveira-Filho; L B Valle; J L Barañao; V G Foglia; Eduardo H Charreau
Nuclear androgen receptors in prostates from diabetic rats.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1982;14(5):237-40.
1982: María Eugenia Escobar; Selva B Cigorraga; V A Chiauzzi; Eduardo H Charreau; Marco A Rivarola
Development of the gonadotrophic resistant ovary syndrome in myasthenia gravis: suggestion of similar autoimmune mechanisms.
Acta endocrinologica 1982;99(3):431-6.
1982: Eduardo H Charreau; V Chiauzzi; Selva B Cigorraga; María Eugenia Escobar; Marco A Rivarola
Immunoglobulin anti FSH receptor in the resistant ovary syndrome.
Progress in clinical and biological research 1982;112 Pt A():111-21.
1982: Ricardo S Calandra; J L Barañao; L Bertini; J C Calvo; Eduardo H Charreau; V A Chiauzzi; M O Suescun; Marta Tesone
Effects of prolactin on the male gonad and sex accessory organs.
Progress in clinical and biological research 1982;87():87-112.
1981: Eduardo H Charreau; J C Calvo; K Nozu; Omar P Pignataro; K J Catt; M L Dufau
Hormonal modulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in gonadotropin-stimulated and -desensitized testicular Leydig cells.
The Journal of biological chemistry 1981;256(24):12719-24.
1981: J L Barañao; B Legnani; V A Chiauzzi; L M Bertini; M O Suescun; J C Calvo; Eduardo H Charreau; Ricardo S Calandra
Effects of prolactin on androgen metabolism in androgen target tissues of immature rats.
Endocrinology 1981;109(6):2188-95.
1981: J L Barañao; Hector E Chemes; Marta Tesone; V A Chiauzzi; Pablo Scacchi; J C Calvo; M R Faigon; Jaime A Moguilevsky; Eduardo H Charreau; Ricardo S Calandra
Effects of androgen treatment of the neonate on rat testis and sex accessory organs.
Biology of reproduction 1981;25(4):851-8.
1981: J C Calvo; L Finocchiaro; I Lüthy; Eduardo H Charreau; Ricardo S Calandra; B Engström; V Hansson
Specific prolactin binding in the rat adrenal gland: its characterization and hormonal regulation.
The Journal of endocrinology 1981;89(2):317-25.
1980: Marta Tesone; R M Oliveira-Filho; L B Valle; J C Calvo; J L Barañao; V G Foglia; Eduardo H Charreau
Androgen receptors in the diabetic rat.
Diabetologia 1980;18(5):385-90.
1980: Marta Tesone; R M Oliveira-Filho; Eduardo H Charreau
Prolactin binding in rat Langerhans islets.
Journal of receptor research 1980;1(3):355-72.